Previous data show that, when measured as IgG antibodies against S protein or RBD and neutralizing antibodies, immune response after two doses of the SARS-CoV-2 vaccine is similar to that observed in convalescent sera from COVID-19 patients [27,28,29,30]. The gene discussed is PROS1; the disease is COVID-19.